Skip to content
10-Q/A

Quarterly Report

Orion Biotech Opportunities Corp.

0001213900-21-066369

← back to feed
Filed
Dec 20, 2021 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q3 2021 · Sep 30, 2021 −$1.15M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $780.42K
Stockholders Equity Q3 2021 · Sep 30, 2021 −$12.86M
Stockholders Equity Q3 2021 · Jun 30, 2021 −$15.12M
Stockholders Equity Q3 2021 · Mar 31, 2021 −$20.09K
Current Liabilities Q3 2021 · Sep 30, 2021 $82.92K
Total Liabilities Q3 2021 · Sep 30, 2021 $14.42M
Current Assets Q3 2021 · Sep 30, 2021 $1.56M
Total Assets Q3 2021 · Sep 30, 2021 $201.56M
Sga Expense Q3 2021 · Sep 30, 2021 $194.47K
Sga Expense Q3 2021 · Sep 30, 2021 $378.66K
Net Income Q3 2021 · Sep 30, 2021 $2.26M
Net Income Q3 2021 · Sep 30, 2021 $171.16K
Operating Income Q3 2021 · Sep 30, 2021 −$224.47K
Operating Income Q3 2021 · Sep 30, 2021 −$423.18K